PANEL DISCUSSION – The Road Ahead: Topicals vs Orals vs Alternative Delivery Methods
Time: 9:30 am
day: Day One
Details:
- Exploring the JAK inhibitor drug development landscape and weighing the merit of pursuing topical vs oral vs
alternative application - Considering the cost concerns and systemic effects associated with oral and injectable delivery systems whilst
discussing the small potential for off-target effects in topical creams - Discussing the need to equate disease severity and quality of life with safety concerns associated with JAK inhibition
- Reflecting on the practicality of topical delivery as a long-term disease management strategy
